Demb Joshua, Chu Philip, Nelson Thomas, Hall David, Seibert Anthony, Lamba Ramit, Boone John, Krishnam Mayil, Cagnon Christopher, Bostani Maryam, Gould Robert, Miglioretti Diana, Smith-Bindman Rebecca
Department of Epidemiology and Biostatistics, University of California, San Francisco.
Department of Radiology, University of California, San Francisco.
JAMA Intern Med. 2017 Jun 1;177(6):810-817. doi: 10.1001/jamainternmed.2017.0445.
Radiation doses for computed tomography (CT) vary substantially across institutions.
To assess the impact of institutional-level audit and collaborative efforts to share best practices on CT radiation doses across 5 University of California (UC) medical centers.
DESIGN, SETTING, AND PARTICIPANTS: In this before/after interventional study, we prospectively collected radiation dose metrics on all diagnostic CT examinations performed between October 1, 2013, and December 31, 2014, at 5 medical centers. Using data from January to March (baseline), we created audit reports detailing the distribution of radiation dose metrics for chest, abdomen, and head CT scans. In April, we shared reports with the medical centers and invited radiology professionals from the centers to a 1.5-day in-person meeting to review reports and share best practices.
We calculated changes in mean effective dose 12 weeks before and after the audits and meeting, excluding a 12-week implementation period when medical centers could make changes. We compared proportions of examinations exceeding previously published benchmarks at baseline and following the audit and meeting, and calculated changes in proportion of examinations exceeding benchmarks.
Of 158 274 diagnostic CT scans performed in the study period, 29 594 CT scans were performed in the 3 months before and 32 839 CT scans were performed 12 to 24 weeks after the audit and meeting. Reductions in mean effective dose were considerable for chest and abdomen. Mean effective dose for chest CT decreased from 13.2 to 10.7 mSv (18.9% reduction; 95% CI, 18.0%-19.8%). Reductions at individual medical centers ranged from 3.8% to 23.5%. The mean effective dose for abdominal CT decreased from 20.0 to 15.0 mSv (25.0% reduction; 95% CI, 24.3%-25.8%). Reductions at individual medical centers ranged from 10.8% to 34.7%. The number of CT scans that had an effective dose measurement that exceeded benchmarks was reduced considerably by 48% and 54% for chest and abdomen, respectively. After the audit and meeting, head CT doses varied less, although some institutions increased and some decreased mean head CT doses and the proportion above benchmarks.
Reviewing institutional doses and sharing dose-optimization best practices resulted in lower radiation doses for chest and abdominal CT and more consistent doses for head CT.
计算机断层扫描(CT)的辐射剂量在各机构之间差异很大。
评估机构层面的审核以及分享最佳实践的协作努力对加州大学(UC)5个医学中心CT辐射剂量的影响。
设计、背景和参与者:在这项干预前后的研究中,我们前瞻性地收集了2013年10月1日至2014年12月31日期间在5个医学中心进行的所有诊断性CT检查的辐射剂量指标。利用1月至3月的数据(基线),我们创建了审核报告,详细说明了胸部、腹部和头部CT扫描的辐射剂量指标分布情况。4月,我们与各医学中心分享了报告,并邀请各中心的放射学专业人员参加为期1.5天的面对面会议,以审核报告并分享最佳实践。
我们计算了审核和会议前后12周平均有效剂量的变化,不包括医学中心可以进行更改的12周实施期。我们比较了基线时以及审核和会议后超过先前公布基准的检查比例,并计算了超过基准的检查比例的变化。
在研究期间进行的158274次诊断性CT扫描中,在审核和会议前3个月进行了29594次CT扫描,在审核和会议后12至24周进行了32839次CT扫描。胸部和腹部的平均有效剂量有显著降低。胸部CT的平均有效剂量从13.2 mSv降至10.7 mSv(降低了18.9%;95%CI,18.0%-19.8%)。各医学中心的降幅在3.8%至23.5%之间。腹部CT的平均有效剂量从20.0 mSv降至15.0 mSv(降低了25.0%;95%CI,24.3%-25.8%)。各医学中心的降幅在10.8%至34.7%之间。有效剂量测量超过基准的胸部和腹部CT扫描数量分别大幅减少了48%和54%。审核和会议后,头部CT剂量的变化较小,尽管一些机构的头部CT平均剂量有所增加,一些机构有所降低,且超过基准的比例也有所变化。
审核机构剂量并分享剂量优化最佳实践可降低胸部和腹部CT的辐射剂量,并使头部CT剂量更加一致。